Ionis wins FDA approval of Alexander disease drug zilganersen
Ionis Pharmaceuticals got FDA approval of its rare neurodegenerative disease treatment zilganersen, paving the way for the company’s first wholly owned neurology product. Ionis' drug is an RNA-based therapy for children ...
September 4, 2026 10:46 AM EDT PharmaFDA+ Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval Ayisha Sharma News Reporter Ionis Pharmaceuticals got FDA approval of its rare neurodegenerative disease treatment zilganersen, paving the way for the company’s first wholly owned … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that